decision making

Diseases and
therapeutic areas

and Pharma



About Radiomics

Radiomics is a next generation Liege-based imaging research organization built upon the unparallel experience of its founders, pioneers of the radiomics science.
Radiomics focuses on AI powered healthcare, with a unique expertise in Radiomics, Deep Learning & Federated Learning applied to oncology and other therapeutic areas. Through our proprietary advanced image analysis technology, we aim to unravel the gold mine of hidden data information embedded in standard medical images.
Our final goal is to support insight-based decision making for optimizing pharmaceutical and biotech companies’ clinical trials and drug development studies and for providing clinicians with a patient-centered approach based on personalized medicine. With this aim, Radiomics’ R&D team is continuously working on new solutions, in collaboration with multiple national and international partners.

We can help you



Your clinical trials (in terms of costs and time)



The subtlest signals of drugs efficacy and safety risk


Your crucial
go / no-go


Patients likely to respond to your treatment


Your points
in pay for outcome scenarios

Why Radiomics


Our scientists and clinicians are the ones who invented radiomics and have unparalleled experience and international recognition in this AI field.


Radiomics has clients and partners in the EU, the US, Africa and Australia. Permanent presence in North America and China are in our plans for the near future.

IP Portfolio

Radiomics' comprehensive IP portfolio includes both granted and pending international (EU/US) patents.


Radiomics' team is composed of a multicultural and multidisciplinary set of people, specialized in a broad range of domains always enthusiastic in addressing clients and partner's needs. 


Radiomics has numerous publications in high impact journals such as Nature Reviews, Clinical Oncology, Annals of Oncology and many more. 

Latest news

  • August 24th, 2021

First distributed learning network machines for DRAGON installed

Radiomics installed in CHU Liege and University of Florence the first machines required for the connection to the distributed learning network in the framework of DRAGON. This project, funded by the European Commission’s Horizon 2020 program Innovative Medicine Initiative (IMI) aimed at using artificial intelligence (AI) and machine learning to develop decision support systems capable of delivering a more precise coronavirus diagnosis and more accurate predictions of patient outcomes.

  • May 19th, 2021

Visite de Mathieu Michel, Secrétaire d’Etat à la Digitalisation

La société Radiomics est heureuse et fière d’annoncer la visite, ce 19 mai 2021, de Monsieur Mathieu Michel, Secrétaire d’Etat fédéral belge à la Digitalisation, chargé de la Simplification administrative, de la Protection de la vie privée et de la Régie des Bâtiments.

  • May 3rd, 2021

Radiomics Opens its first North American office in Toronto, Ontario

Radiomics is pleased to announce the official opening of its first North American sales and support office with the support of the Walloon investment support agency AWEX. The new office, established in Toronto, Ontario will kick-start the company's partnerships in the area, better accommodating pharma companies and clinicians’ needs through North America-based team members.